Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer ...

Medifast, Inc. MED, a prominent player in the health and wellness industry, is making significant strides to expand its ...

ImmunoPrecise has outperformed the broader market in a spectacular fashion. As of now, IPA’s YTD performance stands at +81.64%, a staggering increase compared to the S&P 500’s YTD performance of just ...

Researchers took drugs currently used to treat type 2 diabetes and obesity and looked into how they affect 175 conditions.

Blue Cross Blue Shield of Michigan is offering buyouts to eligible employees as it copes with financial strain from rising ...